MARKETSDrug Stocks Climb as Investors Digest Midterm Election ResultsBy Armie Margaret LeeNov 7, 2018 12:22 PM EST
MARKETSDrug Stocks Could See an Initial Dip After Democrats Win Control of HouseBy Armie Margaret LeeNov 7, 2018 12:25 AM EST
MARKETSMidterm Elections Could Be Significant for Healthcare StocksBy Armie Margaret LeeNov 5, 2018 12:37 PM EST
MARKETSTeva soars after earnings beat, increased guidanceBy Armie Margaret LeeNov 1, 2018 9:35 AM EDT
MARKETSAllergan Shares Lower Despite Q3 Beat, Increased GuidanceBy Armie Margaret LeeOct 30, 2018 10:00 AM EDT
MARKETSPresident Trump discusses latest proposal to bring down drug costsBy Armie Margaret LeeOct 25, 2018 3:31 PM EDT
MARKETSPresident Trump to return to drug pricing in new speechBy Armie Margaret LeeOct 25, 2018 10:51 AM EDT
MARKETSUnitedHealth Shares Rise After Q3 Beat, Raised GuidanceBy Armie Margaret LeeOct 16, 2018 9:15 AM EDT
INVESTINGCVS-Aetna Deal Gets Conditional Approval from DOJBy Armie Margaret LeeOct 10, 2018 11:27 AM EDT
MARKETSFormer Apple CEO Sees Amazon Playing a Key Role in HealthcareBy Armie Margaret LeeSep 29, 2018 9:56 AM EDT
MARKETSTeva shares pop as FDA approves its migraine drugBy Armie Margaret LeeSep 17, 2018 10:55 AM EDT
MARKETSAmazon-Berkshire-JPM health venture makes 'bold statement' with COO hireBy Armie Margaret LeeSep 6, 2018 1:42 PM EDT
STOCKSAllergan CEO: Botox is in a very strong position despite growing competitionBy Armie Margaret LeeSep 5, 2018 2:24 PM EDT
MARKETSLarge-cap pharma stocks might still have upside despite recent strengthBy Armie Margaret LeeAug 26, 2018 5:33 PM EDT
MARKETSTeva notches win with FDA approval of generic EpiPenBy Armie Margaret LeeAug 16, 2018 4:28 PM EDT
MERGERS AND ACQUISITIONSEpiPen Maker Mylan Announces Plan to Explore OptionsBy Armie Margaret LeeAug 8, 2018 9:19 AM EDT
EARNINGSEli Lilly shares climb on earnings beat, animal health IPO planBy Armie Margaret LeeJul 24, 2018 9:08 AM EDT
MARKETS3 Things to Watch When Biogen Reports Second-Quarter ResultsBy Armie Margaret LeeJul 23, 2018 6:11 PM EDT
MARKETSGSK Shares Climb as Board Is Said to Mull Breakup of Pharma GiantBy Armie Margaret LeeJul 20, 2018 4:52 PM EDT
EARNINGSThree key takeaways from healthcare earnings seasonBy Armie Margaret LeeJul 20, 2018 7:30 AM EDT
INVESTINGAbbott shares rise on second-quarter beat, increased guidanceBy Armie Margaret LeeJul 18, 2018 8:16 AM EDT
EARNINGSAbbott's capital flexibility in focus ahead of earnings releaseBy Armie Margaret LeeJul 17, 2018 4:21 PM EDT
MARKETSUnitedHealth CEO: We See More Tailwinds Than HeadwindsBy Armie Margaret LeeJul 17, 2018 11:23 AM EDT
MARKETSUnitedHealth Shares Fall Despite Q2 Earnings Beat, Raised GuidanceBy Armie Margaret LeeJul 17, 2018 9:18 AM EDT
INVESTINGWhat to watch when UnitedHealth reports resultsBy Armie Margaret LeeJul 16, 2018 3:48 PM EDT
MARKETSPfizer to reorganize itself into 3 business unitsBy Armie Margaret LeeJul 11, 2018 9:56 AM EDT
MARKETSTrump blasts Pfizer for high drug prices in tweet, but stock still risesBy Armie Margaret LeeJul 9, 2018 5:04 PM EDT
MARKETSEvercore likes Becton Dickinson, Medtronic ahead of quarterly resultsBy Armie Margaret LeeJul 9, 2018 12:48 PM EDT
MARKETSAmazon could bring down prescription drug prices following PillPack dealBy Armie Margaret LeeJul 6, 2018 3:56 PM EDT
MARKETSWhy CVS may be less vulnerable to Amazon than WalgreensBy Armie Margaret LeeJun 29, 2018 1:26 PM EDT
MERGERS AND ACQUISITIONSGE Healthcare spinoff prompts split views on M&A effectBy Armie Margaret LeeJun 26, 2018 7:00 PM EDT
MERGERS AND ACQUISITIONSAT&T-Time Warner ruling could usher in more healthcare dealsBy Armie Margaret LeeJun 19, 2018 9:40 AM EDT
MARKETSPTC shares skyrocket on positive data for spinal muscular atrophy drugBy Armie Margaret LeeJun 18, 2018 9:26 AM EDT
MARKETSMylan Slumps in After-Hours Trading on Generic Advair UpdateBy Armie Margaret LeeJun 13, 2018 6:05 PM EDT
MARKETSAT&T-Time Warner Ruling a Positive for Cigna-Express Scripts, CVS-Aetna DealsBy Armie Margaret LeeJun 13, 2018 10:24 AM EDT
MARKETSStryker Says Not in Talks to Buy Boston ScientificBy Armie Margaret LeeJun 13, 2018 9:11 AM EDT
STOCKSAllergan says it's looking to sell two of its unitsBy Armie Margaret LeeMay 30, 2018 12:05 PM EDT
MARKETSCelgene shares rise on plans to increase stock buybacksBy Armie Margaret LeeMay 24, 2018 9:18 AM EDT
MARKETSEli Lilly's Trulicity benefits from growth of diabetes drugsBy Armie Margaret LeeMay 23, 2018 1:39 PM EDT
MARKETSAmgen, Novartis clinch FDA nod on migraine prevention drugBy Armie Margaret LeeMay 18, 2018 11:42 AM EDT
MARKETSAllergan's Meury talks market expansion in aestheticsBy Armie Margaret LeeMay 17, 2018 4:18 PM EDT
MARKETSTeva shares jump after Warren Buffett doubles stake in drugmakerBy Armie Margaret LeeMay 16, 2018 9:34 AM EDT
MARKETSHealthcare Stocks Rebound After President Trump's Speech on Drug PricingBy Armie Margaret LeeMay 11, 2018 6:00 PM EDT
